am I the only one who found oral GLP-1 harder than the injections
Slightly embarrassed to be asking this, but: am I the only one who found oral GLP-1 harder than the injections.
The no-timing-restriction thing is the part I would care about most in practice, and it barely gets mentioned here.
Daily rather than weekly sounds trivial until you think about what a missed dose means in each case.
Went looking for independent testing on this and found essentially nothing, which was clarifying.
Would rather be corrected in public than confident in private.
best — the order this archive was captured in
Milligram comparisons across molecule classes are meaningless. Potency is a property of the molecule at its receptor, not of the number on the label.
Milligram comparisons across molecule classes are meaningless.
Disagreeing with this bit: daily dosing is a different adherence problem, not a better one.
ATTAIN and ACHIEVE are the programmes to keep straight
Assumed the peptide purity conversations transferred and they do not. Different analytical problem entirely.
Are you comparing doses across a small molecule and a peptide?
What analytical method was used — this is not the usual peptide assay question?